Urination

Results: 576



#Item
31ranitidine urination, ranitidine estradiol. ranitidine dose canine ranitidine 150mg side effects lipitor nasacort actos ranitidine ranitidine 75 mg, zantac ranitidine action. ranitidine 300mg tabs antihistamine ranitidin

ranitidine urination, ranitidine estradiol. ranitidine dose canine ranitidine 150mg side effects lipitor nasacort actos ranitidine ranitidine 75 mg, zantac ranitidine action. ranitidine 300mg tabs antihistamine ranitidin

Add to Reading List

Source URL: novasom.com

- Date: 2015-07-05 16:06:51
    32BEHAVIOR SERIES Dealing with Submissive and Excitement Urination

    BEHAVIOR SERIES Dealing with Submissive and Excitement Urination

    Add to Reading List

    Source URL: www.franklincountydogs.com

    Language: English - Date: 2012-12-20 10:37:24
      33Royal Dutch Society for Physical Therapy  Review of the evidence KNGF Guideline for Physical Therapy in patients with

      Royal Dutch Society for Physical Therapy Review of the evidence KNGF Guideline for Physical Therapy in patients with

      Add to Reading List

      Source URL: www.kngfrichtlijnen.nl

      Language: English - Date: 2013-05-07 07:59:28
      34Some tips to solve litter box or inappropriate urination issues Litter box or inappropriate urination problems can be disheartening for any cat owner. All cats know how to use a litter box (it is instinctual) and general

      Some tips to solve litter box or inappropriate urination issues Litter box or inappropriate urination problems can be disheartening for any cat owner. All cats know how to use a litter box (it is instinctual) and general

      Add to Reading List

      Source URL: catadoptionteam.org

      Language: English - Date: 2011-07-01 16:32:54
      35Special Feature  Nippon Shinyaku Launches Zalutia®, a Breakthrough New Drug for Urinary Disorders Caused by Benign Prostatic Hypertrophy Benign prostatic hypertrophy, or BPH, negatively affects a patient’s quality of

      Special Feature Nippon Shinyaku Launches Zalutia®, a Breakthrough New Drug for Urinary Disorders Caused by Benign Prostatic Hypertrophy Benign prostatic hypertrophy, or BPH, negatively affects a patient’s quality of

      Add to Reading List

      Source URL: www.nippon-shinyaku.co.jp

      Language: English - Date: 2014-11-10 02:30:14
      36Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis Wouter Everaertsa,b,c,1, Xiaoguang Zhend,1, Debapriya Ghosha,c, Joris Vriensa,c, Thomas Gevaertb,e,

      Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis Wouter Everaertsa,b,c,1, Xiaoguang Zhend,1, Debapriya Ghosha,c, Joris Vriensa,c, Thomas Gevaertb,e,

      Add to Reading List

      Source URL: www.hydrabiosciences.com

      Language: English - Date: 2010-10-21 13:10:05
      37http://www.reuters.com/articlePrint?articleId=US180628%2B24-Jun

      http://www.reuters.com/articlePrint?articleId=US180628%2B24-Jun

      Add to Reading List

      Source URL: www.tarisbiomedical.com

      Language: English - Date: 2009-10-07 13:42:50
      38TARIS® Secures $12.5 Million in Additional Financing; Initiates Phase 2 Trial of Lead Product Candidate Lexington, MA – April 2nd, 2013 – TARIS Biomedical®, a specialty pharmaceutical company developing innovative,

      TARIS® Secures $12.5 Million in Additional Financing; Initiates Phase 2 Trial of Lead Product Candidate Lexington, MA – April 2nd, 2013 – TARIS Biomedical®, a specialty pharmaceutical company developing innovative,

      Add to Reading List

      Source URL: www.tarisbiomedical.com

      Language: English - Date: 2013-04-02 09:23:50
      39TARIS SUCCESSFULLY COMPLETES PHASE 1 STUDY -- First Human Trial Enables Development for Several Indications -Lexington, MA – December 2, 2009 – TARIS Biomedical, a specialty pharmaceutical company pioneering the fiel

      TARIS SUCCESSFULLY COMPLETES PHASE 1 STUDY -- First Human Trial Enables Development for Several Indications -Lexington, MA – December 2, 2009 – TARIS Biomedical, a specialty pharmaceutical company pioneering the fiel

      Add to Reading List

      Source URL: www.tarisbiomedical.com

      Language: English - Date: 2009-12-02 18:21:00
      40TARIS® Announces Dosing of First Patient in Second Phase 2 Clinical Study of LiRIS® in Interstitial Cystitis Lexington, MA – April 2nd, 2013 – TARIS Biomedical®, a specialty pharmaceutical company developing innov

      TARIS® Announces Dosing of First Patient in Second Phase 2 Clinical Study of LiRIS® in Interstitial Cystitis Lexington, MA – April 2nd, 2013 – TARIS Biomedical®, a specialty pharmaceutical company developing innov

      Add to Reading List

      Source URL: www.tarisbiomedical.com

      Language: English - Date: 2013-04-02 09:23:57